Globus Medical (GMED) Reports Preliminary Sales Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Globus Medical (GMED) PT Raised to $101 at Canaccord Genuity
January 10, 2025 6:37 AM ESTCanaccord Genuity analyst William J. Plovanic raised the price target on Globus Medical (NYSE: GMED) to $101.00 (from $92.00) while maintaining a Buy rating.
The analyst comments "Model Update: We are updating our model post GMED's Q4/24 preannouncement last evening. As a reminder, last night GMED... More
